Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Gertrudis Rojas, Yaima Tundidor & Yanelys Cabrera Infante. (2014) High throughput functional epitope mapping: Revisiting phage display platform to scan target antigen surface. mAbs 6:6, pages 1368-1376.
Read now
Read now
Articles from other publishers (12)
Brian J. Thomas, Caitlyn Guldenpfennig, Yue Guan, Calvin Winkler, Margaret Beecher, Michaela Beedy, Ashley F. Berendzen, Lixin Ma, Mark A. Daniels, Donald H. Burke & David Porciani. (2023) Targeting lung cancer with clinically relevant EGFR mutations using anti-EGFR RNA aptamer. Molecular Therapy - Nucleic Acids 34, pages 102046.
Crossref
Crossref
Dayana Pérez-Martínez, Yanelys Cabrera Infante, Belinda Sánchez Ramírez & Gertrudis Rojas. (2022) Domain-level epitope mapping of polyclonal antibodies against HER-1 and HER-2 receptors using phage display technology. Scientific Reports 12:1.
Crossref
Crossref
Yanping Huang, Xiangdan Cuan, Xingying Yang, Weiwei Zhu, Yunli Zhao, Li Jiang, Chengting Zi, Xuanjun Wang & Jun Sheng. (2022) Oxidized tea polyphenol (OTP-3) targets EGFR synergistic nimotuzumab at inhibition of non-small cell lung tumor growth. Bioorganic Chemistry 128, pages 106084.
Crossref
Crossref
Sandra González Fernández, Yohan Amador García, Lucien Gregoria Boris Porras, Liuba Mojena Martínez, Luis Laureano Soler Porro, Gustavo Pish Martí, Liem Fonseca Chon, Yelec Estrada Guerra, Jorge Manuel Álvarez Blanco, Acralys Garabito Perdomo, Félix Bárbaro Santel Odio, Luis Alfonso Varona Vázquez, Yoel Mario Ricardo Serrano, Lisette Chao González, Yisel Avila Albuerne, Lizet Sánchez Valdés, Carmen Elena Viada González, Mayra Ramos Suzarte & Yaimarelis Saumell Nápoles. (2022) Nimotuzumab in the Treatment of Inoperable Esophageal Tumors of Epithelial Origin. Journal of Oncology 2022, pages 1-11.
Crossref
Crossref
Gertrudis Rojas. (2022) Understanding and Modulating Antibody Fine Specificity: Lessons from Combinatorial Biology. Antibodies 11:3, pages 48.
Crossref
Crossref
Seyedeh Roghayeh Hamidi, Yaghoub Safdari & Mehdi Sheikh Arabi. (2022) FITC-conjugated single chain Nimotuzumab can specifically recognize and enter EGFR-overexpressing cells. International Journal of Peptide Research and Therapeutics 28:3.
Crossref
Crossref
Girgis Obaid, Kimberley Samkoe, Kenneth Tichauer, Shazia Bano, Yeonjae Park, Zachary Silber, Sassan Hodge, Susan Callaghan, Mina Guirguis, Srivalleesha Mallidi, Brian Pogue & Tayyaba Hasan. (2020) Is tumor cell specificity distinct from tumor selectivity in vivo? A quantitative NIR molecular imaging analysis of nanoliposome targeting. Nano Research 14:5, pages 1344-1354.
Crossref
Crossref
Tania Crombet Ramos, Braulio Mestre Fernández, Zaima Mazorra Herrera & Normando E. Iznaga Escobar. (2020) Nimotuzumab for Patients With Inoperable Cancer of the Head and Neck. Frontiers in Oncology 10.
Crossref
Crossref
Takuya Hasezaki, Tadahiko Yoshima, Mikael Mattsson, Anna Särnefält & Keiko Takubo. (2020) A monoclonal antibody recognizing a new epitope on CD81 inhibits T-cell migration without inducing cytokine production. The Journal of Biochemistry 167:4, pages 399-409.
Crossref
Crossref
Yaima Tundidor, Luis F. Ponce, Lisset Chao, Joaquín Solozábal, Michael Hust, Stefan Dübel & Gertrudis Rojas. (2020) Affinity-matured variants derived from nimotuzumab keep the original fine specificity and exhibit superior biological activity. Scientific Reports 10:1.
Crossref
Crossref
Conrad Chan, Humphrey Fonge, Karen Lam & Raymond M. Reilly. (2020) Effectiveness and normal tissue toxicity of Auger electron (AE) radioimmunotherapy (RIT) with [111In]In-Bn-DTPA-nimotuzumab in mice with triple-negative or trastuzumab-resistant human breast cancer xenografts that overexpress EGFR. Nuclear Medicine and Biology 80-81, pages 37-44.
Crossref
Crossref
Timothy L. Fitzgerald, Kvin Lertpiriyapong, Lucio Cocco, Alberto M. Martelli, Massimo Libra, Saverio Candido, Giuseppe Montalto, Melchiorre Cervello, Linda Steelman, Stephen L. Abrams & James A. McCubrey. (2015) Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells. Advances in Biological Regulation 59, pages 65-81.
Crossref
Crossref